Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17065408rdf:typepubmed:Citationlld:pubmed
pubmed-article:17065408lifeskim:mentionsumls-concept:C0078058lld:lifeskim
pubmed-article:17065408lifeskim:mentionsumls-concept:C0032005lld:lifeskim
pubmed-article:17065408lifeskim:mentionsumls-concept:C0032019lld:lifeskim
pubmed-article:17065408lifeskim:mentionsumls-concept:C0597357lld:lifeskim
pubmed-article:17065408lifeskim:mentionsumls-concept:C0542341lld:lifeskim
pubmed-article:17065408lifeskim:mentionsumls-concept:C1511790lld:lifeskim
pubmed-article:17065408lifeskim:mentionsumls-concept:C0205307lld:lifeskim
pubmed-article:17065408lifeskim:mentionsumls-concept:C1171892lld:lifeskim
pubmed-article:17065408lifeskim:mentionsumls-concept:C0475264lld:lifeskim
pubmed-article:17065408pubmed:issue1lld:pubmed
pubmed-article:17065408pubmed:dateCreated2006-10-26lld:pubmed
pubmed-article:17065408pubmed:abstractTextAs for any solid tumour, pituitary adenoma expansion is dependent on neovascularization through angiogenesis. In this process, vascular endothelial growth factor (VEGF) and its receptors VEGFR-1, VEGFR-2 and neuropilin-1 (NRP-1) may play an outstanding role. The intention of this work was to study the expression/localization and possible function of VEGF receptors in pituitary adenomas. VEGF receptor mRNA and protein expression was studied by in situ hybridization, immunohistochemistry and RT-PCR in 6 normal human pituitaries, 39 human pituitary adenomas and 4 rodent pituitary adenoma cell lines. VEGFR-1 expressing somatotroph MtT-S cells were used as a model to study the role of VEGF on cell proliferation and to elucidate the underlying mechanism of action. In normal pituitaries, VEGFR-1 was detected in endocrine cells, whereas VEGFR-2 and NRP-1 were exclusively expressed in endothelial cells. In pituitary tumours, a heterogeneous VEGFR expression pattern was observed by IHC. VEGFR-1, VEGFR-2 and NRP-1 were detected in 24, 18 and 17 adenomas respectively. In the adenomas, VEGFR-1 was expressed in epithelial tumour cells and VEGFR-2/NRP-1 in vessel endothelial cells. Functional studies in VEGFR-1-positive MtT-S cells showed that the ligands of VEGFR-1 significantly stimulated cell proliferation. This effect was mediated through the phosphatidylinositol-3-kinase-signalling pathway and involves induction of cyclin D1 and Bcl-2. Based on our results, we speculate that the ligands of VEGF receptors, such as VEGF-A and placenta growth factor, not only play a role in angiogenesis in pituitary adenomas, but also affect the growth of pituitary tumour cells through VEGFR-1.lld:pubmed
pubmed-article:17065408pubmed:languageenglld:pubmed
pubmed-article:17065408pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17065408pubmed:citationSubsetIMlld:pubmed
pubmed-article:17065408pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17065408pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17065408pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17065408pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17065408pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17065408pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17065408pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17065408pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17065408pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17065408pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17065408pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17065408pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17065408pubmed:statusMEDLINElld:pubmed
pubmed-article:17065408pubmed:monthOctlld:pubmed
pubmed-article:17065408pubmed:issn0022-0795lld:pubmed
pubmed-article:17065408pubmed:authorpubmed-author:LosaMarcoMlld:pubmed
pubmed-article:17065408pubmed:authorpubmed-author:LangeManfredMlld:pubmed
pubmed-article:17065408pubmed:authorpubmed-author:ArztEduardoElld:pubmed
pubmed-article:17065408pubmed:authorpubmed-author:StallaGünter...lld:pubmed
pubmed-article:17065408pubmed:authorpubmed-author:UhlEberhardElld:pubmed
pubmed-article:17065408pubmed:authorpubmed-author:OnofriChiaraClld:pubmed
pubmed-article:17065408pubmed:authorpubmed-author:RennerUlrichUlld:pubmed
pubmed-article:17065408pubmed:authorpubmed-author:Theodoropoulo...lld:pubmed
pubmed-article:17065408pubmed:issnTypePrintlld:pubmed
pubmed-article:17065408pubmed:volume191lld:pubmed
pubmed-article:17065408pubmed:ownerNLMlld:pubmed
pubmed-article:17065408pubmed:authorsCompleteYlld:pubmed
pubmed-article:17065408pubmed:pagination249-61lld:pubmed
pubmed-article:17065408pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:17065408pubmed:meshHeadingpubmed-meshheading:17065408...lld:pubmed
pubmed-article:17065408pubmed:meshHeadingpubmed-meshheading:17065408...lld:pubmed
pubmed-article:17065408pubmed:meshHeadingpubmed-meshheading:17065408...lld:pubmed
pubmed-article:17065408pubmed:meshHeadingpubmed-meshheading:17065408...lld:pubmed
pubmed-article:17065408pubmed:meshHeadingpubmed-meshheading:17065408...lld:pubmed
pubmed-article:17065408pubmed:meshHeadingpubmed-meshheading:17065408...lld:pubmed
pubmed-article:17065408pubmed:meshHeadingpubmed-meshheading:17065408...lld:pubmed
pubmed-article:17065408pubmed:meshHeadingpubmed-meshheading:17065408...lld:pubmed
pubmed-article:17065408pubmed:meshHeadingpubmed-meshheading:17065408...lld:pubmed
pubmed-article:17065408pubmed:meshHeadingpubmed-meshheading:17065408...lld:pubmed
pubmed-article:17065408pubmed:meshHeadingpubmed-meshheading:17065408...lld:pubmed
pubmed-article:17065408pubmed:meshHeadingpubmed-meshheading:17065408...lld:pubmed
pubmed-article:17065408pubmed:meshHeadingpubmed-meshheading:17065408...lld:pubmed
pubmed-article:17065408pubmed:meshHeadingpubmed-meshheading:17065408...lld:pubmed
pubmed-article:17065408pubmed:meshHeadingpubmed-meshheading:17065408...lld:pubmed
pubmed-article:17065408pubmed:meshHeadingpubmed-meshheading:17065408...lld:pubmed
pubmed-article:17065408pubmed:meshHeadingpubmed-meshheading:17065408...lld:pubmed
pubmed-article:17065408pubmed:meshHeadingpubmed-meshheading:17065408...lld:pubmed
pubmed-article:17065408pubmed:meshHeadingpubmed-meshheading:17065408...lld:pubmed
pubmed-article:17065408pubmed:meshHeadingpubmed-meshheading:17065408...lld:pubmed
pubmed-article:17065408pubmed:meshHeadingpubmed-meshheading:17065408...lld:pubmed
pubmed-article:17065408pubmed:meshHeadingpubmed-meshheading:17065408...lld:pubmed
pubmed-article:17065408pubmed:meshHeadingpubmed-meshheading:17065408...lld:pubmed
pubmed-article:17065408pubmed:meshHeadingpubmed-meshheading:17065408...lld:pubmed
pubmed-article:17065408pubmed:meshHeadingpubmed-meshheading:17065408...lld:pubmed
pubmed-article:17065408pubmed:meshHeadingpubmed-meshheading:17065408...lld:pubmed
pubmed-article:17065408pubmed:meshHeadingpubmed-meshheading:17065408...lld:pubmed
pubmed-article:17065408pubmed:meshHeadingpubmed-meshheading:17065408...lld:pubmed
pubmed-article:17065408pubmed:meshHeadingpubmed-meshheading:17065408...lld:pubmed
pubmed-article:17065408pubmed:meshHeadingpubmed-meshheading:17065408...lld:pubmed
pubmed-article:17065408pubmed:year2006lld:pubmed
pubmed-article:17065408pubmed:articleTitleLocalization of vascular endothelial growth factor (VEGF) receptors in normal and adenomatous pituitaries: detection of a non-endothelial function of VEGF in pituitary tumours.lld:pubmed
pubmed-article:17065408pubmed:affiliationMax-Planck-Institute of Psychiatry, Neuroendocrinology Group, Kraepelinstr. 10, D-80804 Munich, Germany. onofri@mpipsykl.mpg.delld:pubmed
pubmed-article:17065408pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17065408pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17065408lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17065408lld:pubmed